Acid-Suppressing Agents and Risk for Clostridium difficile Infection in Pediatric Patients (Q41508412)

1 October 2017

Acid-Suppressing Agents and Risk for Clostridium difficile Infection in Pediatric Patients (English)

1 reference

1 October 2017

Clostridium difficile

0 references

author name string

Katelyn E Brown

1

1 reference

1 October 2017

Chad A Knoderer

2

1 reference

1 October 2017

Kristen R Nichols

3

1 reference

1 October 2017

Ashley S Crumby

4

1 reference

1 October 2017

2 February 2015

1 reference

1 October 2017

1 reference

1 October 2017

54

1 reference

1 October 2017

11

1 reference

1 October 2017

1102-1106

1 reference

Clostridium difficile infection in hospitalized children in the United States

1 October 2017

1 reference

https://api.crossref.org/works/10.1177%2F0009922815569201

Clostridium difficile infection in the hospitalized pediatric population: increasing trend in disease incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922815569201

Clostridium difficile Infection in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922815569201

Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922815569201

Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922815569201

Clinical factors associated with development of severe-complicated Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922815569201

Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922815569201

The association between histamine 2 receptor antagonist use and Clostridium difficile infection: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922815569201

Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922815569201

Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922815569201

Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922815569201

Epidemiologic surveillance of Clostridium difficile diarrhea in a freestanding pediatric hospital and a pediatric hospital at a university medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922815569201

Clostridium difficile infection and proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922815569201

Clostridium difficile infection in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922815569201

Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922815569201

Who is using chronic acid suppression therapy and why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922815569201

21 January 2018

Identifiers

DOI

10.1177/0009922815569201

1 reference

1 October 2017

1 reference